Unknown

Dataset Information

0

Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides.


ABSTRACT: Splice-switching antisense oligonucleotides (ASOs), which bind specific RNA-target sequences and modulate pre-mRNA splicing by sterically blocking the binding of splicing factors to the pre-mRNA, are a promising therapeutic modality to treat a range of genetic diseases. ASOs are typically 15-25 nt long and considered to be highly specific towards their intended target sequence, typically elements that control exon definition and/or splice-site recognition. However, whether or not splice-modulating ASOs also induce hybridization-dependent mis-splicing of unintended targets has not been systematically studied. Here, we tested the in vitro effects of splice-modulating ASOs on 108 potential off-targets predicted on the basis of sequence complementarity, and identified 17 mis-splicing events for one of the ASOs tested. Based on analysis of data from two overlapping ASO sequences, we conclude that off-target effects are difficult to predict, and the choice of ASO chemistry influences the extent of off-target activity. The off-target events caused by the uniformly modified ASOs tested in this study were significantly reduced with mixed-chemistry ASOs of the same sequence. Furthermore, using shorter ASOs, combining two ASOs, and delivering ASOs by free uptake also reduced off-target activity. Finally, ASOs with strategically placed mismatches can be used to reduce unwanted off-target splicing events.

SUBMITTER: Scharner J 

PROVIDER: S-EPMC6954394 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides.

Scharner Juergen J   Ma Wai Kit WK   Zhang Qian Q   Lin Kuan-Ting KT   Rigo Frank F   Bennett C Frank CF   Krainer Adrian R AR  

Nucleic acids research 20200101 2


Splice-switching antisense oligonucleotides (ASOs), which bind specific RNA-target sequences and modulate pre-mRNA splicing by sterically blocking the binding of splicing factors to the pre-mRNA, are a promising therapeutic modality to treat a range of genetic diseases. ASOs are typically 15-25 nt long and considered to be highly specific towards their intended target sequence, typically elements that control exon definition and/or splice-site recognition. However, whether or not splice-modulati  ...[more]

Similar Datasets

| S-EPMC5001604 | biostudies-literature
| S-EPMC8302632 | biostudies-literature
| S-EPMC7393423 | biostudies-literature
| S-EPMC4098814 | biostudies-literature
| S-EPMC8583451 | biostudies-literature
| S-EPMC3001088 | biostudies-other
| S-EPMC3423875 | biostudies-other